Rani Therapeutics Expands its Collaboration with Celltrion to Develop Oral Version of Humira Biosimilar RT-105
Shots: The recent collaboration was based on the Celltrion's previous agreemen...
Shots: The recent collaboration was based on the Celltrion's previous agreemen...
Shots: The P-I study evaluating PK & PD of proposed tocilizumab biosimilar DRL...
Shots: The EC has granted marketing authorization for Epysqli, a biosimilar refere...
Shots: The companies collaborated to launch Cetuximab, the first biosimilar develo...
Shots: The EMA has accepted the MAA for the proposed biosimilar denosumab (Prolia...
Shots: The US FDA has approved Yuflyma (adalimumab-aaty) as the ninth biosimilar r...
Incisive News in 3 Shots.